EZR and carcinoma: One possible explanation could be that ezrin, which is related to the FAK and RhoB, may have a critical role in progression and metastasis in carcinomas and resistance to chemotherapy in osteosarcoma cell lines, and thereby increased expression of ezrin may contribute to worse clinical outcomes of patients with osteosarcoma [33].